MYX mayne pharma group limited

Ann: 2015 Full Year Results Media Release, page-2

  1. 170 Posts.
    lightbulb Created with Sketch. 18
    Its very quiet here following the full year release - no huge increase yet in SP, market not completely satisfied?

    Its interesting to note that revenue was down slightly from the previous FY, especially the 1st half with a large increase in the 2nd half.

    I found this comment interesting also

    "Significant growth expected in FY16 driven by recent product acquisitions, new product launches, increased market penetration of existing products and accelerated growth in Metrics Contract Services"

    I can see huge potentials for this company and the current SP seems a bargain for investors.

    Anyone else have any thoughts/comments?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.05
Change
-0.020(0.39%)
Mkt cap ! $411.9M
Open High Low Value Volume
$5.05 $5.08 $5.05 $85.05K 16.78K

Buyers (Bids)

No. Vol. Price($)
6 15390 $5.05
 

Sellers (Offers)

Price($) Vol. No.
$5.06 215 7
View Market Depth
Last trade - 12.13pm 07/08/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.